Effect of the <scp>SGLT2</scp> inhibitor ipragliflozin on the expression of genes that regulate skin function
It was revealed that ipragliflozin reduces the expression of genes involved in skin barrier and moisturizing functions, which this may be one of the mechanisms through which this drug causes skin disorders.
Authors
- Hiroyasu Sakai (ORCID: https://orcid.org/0000-0002-4501-2836)
- Keito Tabata
- Risako Kon
- Tomoo Hosoe (ORCID: https://orcid.org/0000-0002-0877-6263)
- Nobutomo Ikarashi (ORCID: https://orcid.org/0000-0001-6991-2946)
- Yui Shinozaki
Institutions
- Hoshi University (JP)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1111/dme.15505
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00